The Indiana Clinical Trials Center
Plainfield, Indiana, United States
Dermatologist in Plainfield, Indiana
824 Edwards Dr Suite 172, Plainfield, IN 46168
About The Indiana Clinical Trials Center
"The Indiana Clinical Trials Center (ICTC) is a comprehensive and highly experienced clinical research site focusing primarily on Phase I - IV dermatologic clinical trials."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
11
Janssen Research & Development, LLC
8
Pfizer
7
LEO Pharma
6
DUSA Pharmaceuticals, Inc.
5
Concert Pharmaceuticals
4
Journey Medical Corporation
3
Peplin
3
Actavis Inc.
2
Actavis Mid-Atlantic LLC
2
Amgen
2
Clinical Trials at The Indiana Clinical Trials Center
During the past decade, The Indiana Clinical Trials Center conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 54 clinical trials were completed, i.e. on
average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 35 clinical trials were completed. i.e. 218.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Multicenter Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel When Used to Treat Actinic Keratoses (AKs) on the Non Head Locations
2008-09-01
2009-02-01
Completed
255
Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema
2009-01-08
2012-04-26
Completed
599
A Multi-Center Study to Evaluate the Efficacy and Safety of PEP005 (Ingenol Mebutate) Gel, When Used to Treat Actinic Keratoses on the Head (Face or Scalp)
2009-06-01
2009-09-01
Completed
278
A Long Term Follow up Study of Patients Who Have Completed the PEP005-016 or PEP005-025 Studies
2009-08-01
2010-10-01
Completed
117
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne
2009-09-01
2011-05-01
Completed
925
LEO 80185 in the Treatment of Psoriasis Vulgaris on the Non-scalp Regions of the Body (Trunk and/or Limbs)
2010-09-01
2011-03-01
Completed
1,152
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris
2010-09-01
2011-12-01
Completed
180
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Indiana Clinical Trials Center" #1 sponsor was "Eli Lilly and Company" with 11 trials, followed by "Janssen Research & Development, LLC" with 8 trials
sponsored, "Pfizer" with 7 trials sponsored, "LEO Pharma" with 6 trials sponsored and "DUSA Pharmaceuticals, Inc."
with 6 trials sponsored. Other sponsors include 51 different institutions and
companies that sponsored additional 43 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Indiana Clinical Trials Center"
#1 collaborator was "Dermira, Inc." with 4 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Athenex, Inc." with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator and "BioClinica, Inc." with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were
collaborators in the rest 12 trials.
Clinical Trials Conditions at The Indiana Clinical Trials Center
According to Clinical.Site data, the most researched conditions in "The Indiana Clinical Trials Center" are
"Atopic Dermatitis" (19 trials), "Actinic Keratosis" (11 trials), "Plaque Psoriasis" (11 trials), "Psoriasis" (9 trials) and "Acne Vulgaris" (8 trials). Many other conditions were trialed in "The Indiana Clinical Trials Center" in a lesser frequency.
Clinical Trials Intervention Types at The Indiana Clinical Trials Center
Most popular intervention types in "The Indiana Clinical Trials Center" are "Drug" (86 trials), "Other" (10 trials), "Biological" (7 trials), "Device" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (38 trials), "Vehicle" (9 trials), "Lebrikizumab" (5 trials), "Guselkumab" (4 trials) and "CTP-543" (3 trials). Other intervention names were less common.
Clinical Trials Genders at The Indiana Clinical Trials Center
The vast majority of trials in "The Indiana Clinical Trials Center" are
92 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at The Indiana Clinical Trials Center
Currently, there are NaN active trials in "The Indiana Clinical Trials Center".
undefined are not yet recruiting,
6 are recruiting,
4 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 72 completed trials in The Indiana Clinical Trials Center,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in The Indiana Clinical Trials Center, 3 "Phase 1"
clinical trials were conducted, 38 "Phase 2" clinical
trials and 47 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 2 trials that are defined as “Not Applicable".